Joel Isaacson & Co’s Core Laboratories CLB Stock Holding History

Joel Isaacson & Co’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-1,200	Closed	-$144K	–	241
2016 Q4	$144K	Hold	1,200	–	–	0.03%	181
2016 Q3	$135K	Hold	1,200	–	–	0.03%	200
2016 Q2	$149K	Hold	1,200	–	–	0.03%	195
2016 Q1	$135K	Hold	1,200	–	–	0.03%	210
2015 Q4	$130K	Hold	1,200	–	–	0.03%	199
2015 Q3	$120K	Hold	1,200	–	–	0.03%	203
2015 Q2	$137K	Hold	1,200	–	–	0.04%	215
2015 Q1	$125K	Hold	1,200	–	–	0.03%	224
2014 Q4	$144K	Hold	1,200	–	–	0.04%	192
2014 Q3	$176K	Hold	1,200	–	–	0.05%	139
2014 Q2	$200K	Hold	1,200	–	–	0.06%	125
2014 Q1	$238K	Hold	1,200	–	–	0.08%	104
2013 Q4	$229K	Hold	1,200	–	–	0.08%	97
2013 Q3	$203K	Buy	+1,200	New	+$186K	0.08%	102

Other funds holding CLB

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

SGA

Sustainable Growth Advisers Stamford, Connecticut $10.2B AUM 1.48% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wedgewood Partners St Louis, Missouri $484M AUM 16.04% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Joel Isaacson & Co's CLB Position: Q1 2017 in Review

Joel Isaacson & Co sold out of Core Laboratories (CLB) in Q1 2017, closing a stake of 1,200 shares — an estimated $144K sold.

Joel Isaacson & Co first reported a position in CLB in Q3 2013 and held it in 14 quarters. The position peaked at $238K in Q1 2014. 360 funds tracked by Wall St. Rank hold CLB as of Q1 2017.

Joel Isaacson & Co reported no remaining Core Laboratories position as of Q1 2017 after selling out during the quarter.
Joel Isaacson & Co sold 1,200 Core Laboratories shares in Q1 2017, an estimated $144K.
Joel Isaacson & Co first reported a position in Core Laboratories in Q3 2013 and held it in 14 quarters.
Joel Isaacson & Co's Core Laboratories position peaked at $238K in Q1 2014.
360 funds tracked by Wall St. Rank held Core Laboratories as of Q1 2017.

Based on Joel Isaacson & Co's 13F filing for Q1 2017, filed 5 May 2017.